Variant report
Variant | nsv1031204 |
---|---|
Chromosome Location | chr6:120847713-120870538 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:25)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:25 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr6:120866159-120866410 | HepG2 | liver: | n/a | chr6:120866193-120866205 |
2 | CTCF | chr6:120865300-120865450 | HepG2 | liver: | n/a | n/a |
3 | EBF1 | chr6:120864293-120864398 | GM12878 | blood: | n/a | chr6:120864362-120864372 chr6:120864361-120864372 |
4 | EP300 | chr6:120848216-120848233 | K562 | blood: | n/a | n/a |
5 | HNF4A | chr6:120865800-120865987 | HepG2 | liver: | n/a | chr6:120865904-120865917 chr6:120865903-120865917 chr6:120865901-120865919 chr6:120865907-120865919 chr6:120865903-120865917 |
6 | MAFF | chr6:120856993-120857160 | HepG2 | liver: | n/a | chr6:120857116-120857134 |
7 | MAFF | chr6:120847750-120848084 | HepG2 | liver: | n/a | n/a |
8 | MAFK | chr6:120857001-120857205 | HepG2 | liver: | n/a | chr6:120857119-120857130 chr6:120857118-120857129 chr6:120857117-120857131 chr6:120857118-120857134 chr6:120857118-120857133 |
9 | MAFK | chr6:120847761-120848059 | IMR90 | lung: | n/a | chr6:120847919-120847934 chr6:120847919-120847935 |
10 | MAFK | chr6:120856953-120857248 | HepG2 | liver: | n/a | chr6:120857119-120857130 chr6:120857118-120857129 chr6:120857117-120857131 chr6:120857118-120857134 chr6:120857118-120857133 |
11 | MAFK | chr6:120847839-120848016 | HepG2 | liver: | n/a | chr6:120847919-120847934 chr6:120847919-120847935 |
12 | MAFK | chr6:120847764-120848101 | HepG2 | liver: | n/a | chr6:120847919-120847934 chr6:120847919-120847935 |
13 | MYC | chr6:120847730-120847863 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | POLR2A | chr6:120860934-120860937 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | POLR2A | chr6:120854649-120854979 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | POLR2A | chr6:120862942-120863142 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | POLR2A | chr6:120867923-120867935 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | POLR2A | chr6:120854151-120854264 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | POLR2A | chr6:120848858-120848878 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | POLR2A | chr6:120858326-120858369 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | POLR2A | chr6:120857192-120857374 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | POLR2A | chr6:120869148-120869195 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | POLR2A | chr6:120861566-120861622 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | STAT3 | chr6:120857158-120857358 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | USF1 | chr6:120863165-120863349 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-214P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536267088 | chr6:120847751-120847752 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs184843361 | chr6:120847812-120847813 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs576468464 | chr6:120847825-120847826 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs113327237 | chr6:120847841-120847842 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs553543717 | chr6:120847896-120847897 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs114561130 | chr6:120847898-120847899 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs574974131 | chr6:120847941-120847942 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs540414616 | chr6:120847947-120847948 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs560469863 | chr6:120848010-120848011 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs529176290 | chr6:120848058-120848059 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs542649491 | chr6:120848076-120848077 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs149991382 | chr6:120848101-120848102 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs12198736 | chr6:120848812-120848813 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs532450817 | chr6:120848868-120848869 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs547231957 | chr6:120848893-120848894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181812671 | chr6:120848894-120848895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs71556858 | chr6:120848903-120848904 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs7748628 | chr6:120848904-120848905 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs530229283 | chr6:120848920-120848921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs185258914 | chr6:120848969-120848970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs548244536 | chr6:120849021-120849022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188122459 | chr6:120849096-120849097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs374771841 | chr6:120849125-120849126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570238685 | chr6:120849126-120849127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs180722381 | chr6:120849139-120849140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs372186885 | chr6:120849154-120849155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs369460181 | chr6:120849161-120849162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs6934012 | chr6:120849209-120849210 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs574792786 | chr6:120849240-120849241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114013624 | chr6:120849250-120849251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs143179764 | chr6:120849282-120849283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76573009 | chr6:120849306-120849307 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs186575511 | chr6:120849318-120849319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs115178380 | chr6:120849380-120849381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369610637 | chr6:120849383-120849384 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs540381779 | chr6:120849427-120849428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373646350 | chr6:120849438-120849439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191075396 | chr6:120849460-120849461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148281615 | chr6:120849478-120849479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs141138273 | chr6:120849495-120849496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs71565227 | chr6:120849534-120849535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs71565228 | chr6:120849551-120849552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs9372612 | chr6:120849589-120849590 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs9401284 | chr6:120849596-120849597 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs560646610 | chr6:120849639-120849640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182055042 | chr6:120849643-120849644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570772631 | chr6:120849705-120849706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs117269823 | chr6:120849751-120849752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs72966757 | chr6:120849769-120849770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560088089 | chr6:120849789-120849790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 18698023 | CNVD |
Mental retardation | 18854857 | CNVD |
Leukemia | 18688285 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:120848800-120849000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr6:120849000-120849600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
3 | chr6:120849600-120850600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr6:120850600-120851200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
5 | chr6:120851200-120851400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
6 | chr6:120864600-120864800 | Enhancers | Dnd41 | blood |
7 | chr6:120866600-120869200 | Enhancers | Dnd41 | blood |